Louis successfully defended his PhD research entitled “Inhibiting PI3K/Akt to Enhance Brain Uptake of Anticancer Agents in Glioblastoma.” Louis joined the BHL in 2019 as an MD/PhD student studying the overexpression of drug-efflux pumps in glioblastoma and the development of a novel therapeutic strategy to increase brain uptake of anticancer drugs. Louis will now continue finishing his MD in the College of Medicine at the University of Kentucky. Congratulations, Louis!

Brayden featured in UKNow for CURE Fellowship
UKNow recently featured Brayden’s selection for the 2026 Commonwealth Undergraduate Research Experience (CURE) Fellowship program. As part of the fellowship, Brayden will conduct summer research in the BHL and present his work at the Summer Research Symposium on August 25. You can read the full story HERE.


